Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG:

Eligard (leuprolide acetate)

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Company:

Daewoong Pharma, Recordati, Sanofi, Tolmar

Drug class:

GnRH agonist

Related drugs:

‹

triptorelin (9)

goserelin acetate (7)

histrelin acetate (5)

leuprolide 6-month depot (1)

leuprorelin depot (1)

leuprolide acetate for depot suspension (1)

buserelin acetate (0)

triptorelin (9)

goserelin acetate (7)

histrelin acetate (5)

leuprolide 6-month depot (1)

leuprorelin depot (1)

leuprolide acetate for depot suspension (1)

buserelin acetate (0)

›

No biomarker	Peritoneal Cancer	No biomarker	Peritoneal Cancer	leuprolide acetate Sensitive: A2 - Guideline leuprolide acetate Sensitive : A2	leuprolide acetate Sensitive: A2 - Guideline leuprolide acetate Sensitive : A2
No biomarker	Fallopian Tube Cancer	No biomarker	Fallopian Tube Cancer	leuprolide acetate Sensitive: A2 - Guideline leuprolide acetate Sensitive : A2	leuprolide acetate Sensitive: A2 - Guideline leuprolide acetate Sensitive : A2
No biomarker	Ovarian Cancer	No biomarker	Ovarian Cancer	leuprolide acetate Sensitive: A2 - Guideline leuprolide acetate Sensitive : A2	leuprolide acetate Sensitive: A2 - Guideline leuprolide acetate Sensitive : A2
AR positive	Salivary Gland Cancer	AR positive	Salivary Gland Cancer	leuprolide acetate Sensitive: A2 - Guideline leuprolide acetate Sensitive : A2	leuprolide acetate Sensitive: A2 - Guideline leuprolide acetate Sensitive : A2
No biomarker	Prostate Cancer	No biomarker	Prostate Cancer	leuprolide acetate Sensitive: A2 - Guideline leuprolide acetate Sensitive : A2	leuprolide acetate Sensitive: A2 - Guideline leuprolide acetate Sensitive : A2
No biomarker	Prostate Cancer	No biomarker	Prostate Cancer	abiraterone acetate + leuprolide acetate Sensitive: A2 - Guideline abiraterone acetate + leuprolide acetate Sensitive : A2	abiraterone acetate + leuprolide acetate Sensitive: A2 - Guideline abiraterone acetate + leuprolide acetate Sensitive : A2
No biomarker	Prostate Cancer	No biomarker	Prostate Cancer	leuprolide acetate + bicalutamide Sensitive: A2 - Guideline leuprolide acetate + bicalutamide Sensitive : A2	leuprolide acetate + bicalutamide Sensitive: A2 - Guideline leuprolide acetate + bicalutamide Sensitive : A2
No biomarker	Prostate Cancer	No biomarker	Prostate Cancer	leuprolide acetate + flutamide Sensitive: A2 - Guideline leuprolide acetate + flutamide Sensitive : A2	leuprolide acetate + flutamide Sensitive: A2 - Guideline leuprolide acetate + flutamide Sensitive : A2
No biomarker	Prostate Cancer	No biomarker	Prostate Cancer	leuprolide acetate + nilutamide Sensitive: A2 - Guideline leuprolide acetate + nilutamide Sensitive : A2	leuprolide acetate + nilutamide Sensitive: A2 - Guideline leuprolide acetate + nilutamide Sensitive : A2
AR positive	Salivary Gland Cancer	AR positive	Salivary Gland Cancer	leuprolide acetate + bicalutamide Sensitive: C3 – Early Trials leuprolide acetate + bicalutamide Sensitive : C3	leuprolide acetate + bicalutamide Sensitive: C3 – Early Trials leuprolide acetate + bicalutamide Sensitive : C3
PLIN2 expression	Salivary Gland Cancer	PLIN2 expression	Salivary Gland Cancer	leuprolide acetate + bicalutamide Sensitive: C3 – Early Trials leuprolide acetate + bicalutamide Sensitive : C3	leuprolide acetate + bicalutamide Sensitive: C3 – Early Trials leuprolide acetate + bicalutamide Sensitive : C3
HR positive	HER2 Negative Breast Cancer	HR positive	HER2 Negative Breast Cancer	everolimus + letrozole + leuprolide acetate Sensitive: C3 – Early Trials everolimus + letrozole + leuprolide acetate Sensitive : C3	everolimus + letrozole + leuprolide acetate Sensitive: C3 – Early Trials everolimus + letrozole + leuprolide acetate Sensitive : C3
PTEN expression	Prostate Cancer	PTEN expression	Prostate Cancer	leuprolide acetate + apalutamide Sensitive: C3 – Early Trials leuprolide acetate + apalutamide Sensitive : C3	leuprolide acetate + apalutamide Sensitive: C3 – Early Trials leuprolide acetate + apalutamide Sensitive : C3
AR positive + HER-2 amplification	Salivary Gland Cancer	AR positive + HER-2 amplification	Salivary Gland Cancer	leuprolide acetate + bicalutamide Sensitive: C4 – Case Studies leuprolide acetate + bicalutamide Sensitive : C4	leuprolide acetate + bicalutamide Sensitive: C4 – Case Studies leuprolide acetate + bicalutamide Sensitive : C4